A U.S. District Court judge in Texas ruled that the FDA's approval of mifepristone was illegal, sparking a debate over the future of abortion access in the United States. Democrats have called on the Biden administration to ignore the ruling, but the administration has yet to announce what action it will take. The FDA is expected to make a statement soon.
Posts tagged as “FDA”
The Justice Department has asked a federal judge in Washington state to clarify an order that the FDA maintain the availability of the abortion pill in more than a dozen states, in direct opposition to a Texas decision. A coalition of Democratic attorneys general had filed suit to lift restrictions on the drug, and the Justice Department is now seeking clarification on the order. It remains to be seen how the court will respond and how it will affect the availability of the drug in the states involved.
The Department of Justice has filed a request in a federal appeals court to block a ruling from a Trump-appointed judge that would have endangered access to the abortion pill mifepristone. The Biden administration is arguing that the ruling is "extraordinary and unprecedented" and should be stayed pending appeal. The FDA approved mifepristone in 2000 and it has since become one of the most commonly used abortion pills, used in combination with another drug to terminate a pregnancy.
Biden Administration Prepares to Defend FDA Approval of Abortion Drug Despite Federal Judge’s Ruling
Biden Administration Prepares to Defend FDA Approval of Abortion Drug Despite Federal Judge’s Ruling
The Biden administration has responded to a recent ruling from a federal judge in Texas that suspended the approval of a medication drug used for abortion. Rep. Nancy Mace, a Republican congresswoman, has urged the FDA to ignore the ruling, while Jones, spokeswoman for the Department of Health and Human Services, stated that the agency is prepared to defend the approval through the legal process. The FDA has not yet commented on the ruling or the administration's response, leaving the future of the drug uncertain.
Xavier Becerra, President Joe Biden's health secretary, has spoken out against a court ruling that threatens the availability of a main drug used in medication abortion. The ruling, made by Donald Trump-appointee Matthew Kacsmaryk in Texas, has been met with criticism from reproductive rights advocates. The Biden administration has committed to protecting women's reproductive rights and will do whatever is necessary to ensure that women have access to the medication they need.
The Biden administration is facing a legal challenge that could restrict access to the leading abortion drug in the U.S. A 19th century “anti-vice” law, the Comstock Act, has been revived by anti-abortion groups and conservative states in an effort to block the mailing of mifepristone. HHS Secretary Xavier Becerra has said that all options are on the table to ensure access to the drug, including Supreme Court intervention. Pro-choice advocates have criticized the ruling, arguing that it will have a negative impact on women’s health and rights.
A U.S. District Judge appointed by former President Donald Trump has suspended the FDA's approval of abortion pills, sparking outrage among Congressional Democrats. Chuck Schumer has urged Republicans to speak out against the ruling, while President Joe Biden has said his administration will file an appeal. Republicans in Congress have yet to respond to the ruling.
A federal judge in Texas has issued a stay on the FDA's approval of mifepristone, a drug used for medication abortions, which has been met with criticism from abortion rights advocates. The U.S. Department of Justice and President Joe Biden have both released statements in response to the ruling, and the DOJ has filed an appeal and is seeking an immediate stay of the decision. The outcome of the DOJ's appeal could set a precedent for future cases and have a significant impact on access to abortion services in the United States.